General Biologicals (ROCO:4117) Tariff Resilience Score: 0/10 (As of Jul. 23, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4117 General Biologicals Corp ROCO:4117
50 GF Score
Price NT$10.55
GF Value NT$14.04
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is General Biologicals Tariff Resilience Score?

General Biologicals has the Tariff Resilience Score of 0, which implies that the company might have .

General Biologicals has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes General Biologicals might have .

General Biologicals  (ROCO:4117) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

General Biologicals Tariff Resilience Score Related Terms

ROCO:4117
50GF Score
General Biologicals Corp ROCO:4117
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is General Biologicals (ROCO:4117) Overvalued in 2026?

Based on GuruFocus' analysis, General Biologicals stock appears to be undervalued. The current stock price of NT$10.55 is trading 24.9% below its estimated GF Value™ of NT$14.04. GuruFocus considers General Biologicals to be Modestly Undervalued.

Key valuation signals for ROCO:4117:

  • Tariff Resilience Score: 0
  • GF Value™: NT$14.04 vs. price of NT$10.55 (24.9% below fair value)
  • GF Score™: 50/100 with 8 warning signs

No single metric tells the full story. See the ROCO:4117 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

General Biologicals Business Description

Address No-6, Innovation First Road, Hsinchu Science Park, Hsinchu, TWN, 300092
General Biologicals Corp is a developer and manufacturer of vitro diagnostic devices in Taiwan. It offers research development, marketing and servicing of products and solutions for hospitals, medical laboratories, blood banks, and research and industry. Its products include Anti-HDV, HIV Ag-Ab COMB, Anti-HBs, and many others.
50GF Score

Get the complete analysis for ROCO:4117

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$10.55
Price
NT$14.04
GF Value